Valuation Interpace Biosciences, Inc.

Stocks

Market Closed - OTC Markets Other stock markets 19:08:58 15/07/2026 BST			5-day change	1st Jan Change
1.620 ^USD	0.00%		-0.31%	+31.69%

05-12	Interpace Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-30	Interpace Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	12.69	31.18	4.437	4.693	11.87	5.448
Change	-	145.72%	-85.77%	5.76%	152.98%	-54.11%
Enterprise Value (EV) ¹	14.8	41.84	15.7	12.39	16.27	4.126
Change	-	182.66%	-62.47%	-21.1%	31.32%	-74.64%
P/E	-0.43x	-2.06x	-0.2x	6.03x	6.84x	1.39x
PBR	-0.44x	-0.74x	-0.07x	-0.08x	-5.36x	0.25x
PEG	-	0x	-0x	-0x	0x	0x
Capitalization / Revenue	0.39x	0.75x	0.14x	0.12x	0.25x	0.14x
EV / Revenue	0.46x	1.01x	0.49x	0.31x	0.35x	0.11x
EV / EBITDA	-0.7x	-6.28x	-12.3x	3.23x	1.93x	0.79x
EV / EBIT	-0.56x	-3.56x	-4.09x	4.41x	2.01x	0.86x
EV / FCF	-2.21x	-25.8x	-15.1x	2.93x	11.5x	0.81x
FCF Yield	-45.2%	-3.87%	-6.64%	34.1%	8.66%	123%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-7.322	-3.618	-5.181	0.179	0.3945	0.8852
Distribution rate	-	-	-	-	-	-
Net sales ¹	32.4	41.31	31.84	40.21	46.93	38.73
EBITDA ¹	-21.15	-6.663	-1.28	3.837	8.408	5.209
EBIT ¹	-26.56	-11.74	-3.84	2.811	8.108	4.784
Net income ¹	-26.45	-14.94	-21.96	0.802	6.702	24.58
Net Debt ¹	2.11	10.65	11.26	7.694	4.395	-1.322
Reference price ²	3.140	7.470	1.040	1.080	2.698	1.230
Nbr of stocks (in thousands)	4,042	4,174	4,267	4,345	4,401	4,429
Announcement Date	01/04/21	31/03/22	27/03/23	01/04/24	31/03/25	30/03/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
INTERPACE BIOSCIENCES, INC.	-	-	-	-	44.88M
NATERA, INC.	-163.66x	13.59x	-185.39x	-.--%	39.05B
LABCORP HOLDINGS INC.	19x	1.85x	10.66x	1.06%	22.61B
SONIC HEALTHCARE LIMITED	17.16x	1.34x	7.6x	5.07%	7.39B
RADNET, INC.	321.95x	-	-	-	4.94B
DR. LAL PATHLABS LIMITED	49.5x	8.81x	31.31x	1.05%	3.03B
GENEDX HOLDINGS CORP.	-18.66x	-	-	-	1.85B
NEOGENOMICS, INC.	-31.93x	-	-	-.--%	1.85B
DIAN DIAGNOSTICS GROUP CO.,LTD.	31.15x	1.11x	9.27x	0.81%	1.79B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	35.16x	1.65x	13.07x	1.46%	1.85B
Average	28.85x	4.73x	-18.91x	1.35%	8.44B
Weighted average by Cap.	-48.22x	8.11x	-89.89x	0.89%